Status:

COMPLETED

Concurrent Trigger Sensitivity Adjustment And Diaphragmatic Facilitation On Weaning From Mechanical Ventilation

Lead Sponsor:

Cairo University

Conditions:

Acute Respiratory Failure

Mechanically Ventilated Patients

Eligibility:

All Genders

50-60 years

Phase:

NA

Brief Summary

As Acute respiratory failure (ARF) is a challenging serious condition especially when it necessitates intubation to deliver mechanical ventilation which is a fundamental strategy for supporting the re...

Detailed Description

Physiotherapist is a key member of multidisciplinary team and plays an vital role in ICU in improving the patient's quality of life, Inspiratory muscle training (IMT) applies a load to the diaphragm a...

Eligibility Criteria

Inclusion

  • Patients of both sexes with age ranges (50-60) years old.
  • Patients will be referred with acute respiratory failure (ARF) inside ICU.
  • All patients are intubated and mechanically ventilated with assisted control (pressure or volume) or pressure support modes for 24-48 hours.
  • All patients with positive end expiratory pressure (PEEP) don't exceed 10 cmH2o.
  • All patients are hemodynamically stable; temperature (36.2-37.5) C, Heart rate \< 140 /min, Blood pressure (systolic: \<180mmHg and diastolic \<100 mmHg), Respiratory rate \< 35/min and oxygen saturation \>90%
  • All patients are conscious and responsive to verbal command.

Exclusion

  • Fraction of inspired oxygen (fio2)\>0.6 and SPO2 \< 85% to avoid further hypoxia and respiratory distress.
  • Positive end expiratory pressure (PEEP) \> 10 cmH2O to avoid barotrauma.
  • Severe pulmonary condition; acute pulmonary embolism, undrained pneumothorax.
  • Unstable hemodynamic condition as defined by heart rate more than 140 beats/min, systolic blood pressure \>180 mmHg or Low blood pressure \< 80 mmHg and respiratory rate is exceeding 35 breaths/min.
  • Patients who develop any cardiac condition during the course of treatment; acute myocardial infarction or cardiac arrhythmia.
  • Patients who recently have undergo cardiac or abdominal or gynecological surgery.
  • Active lung infection like tuberculosis.
  • Chest trauma such as rib fracture, flail chest, thoracic vertebra fracture or chest burns.
  • Spinal cord injuries involved the phrenic nerve.
  • Active bleeding as alveolar hemorrhage, hemoptysis.
  • Heavy sedation that depresses respiratory drive or ability to follow commands.

Key Trial Info

Start Date :

December 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2022

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT05387720

Start Date

December 1 2020

End Date

November 30 2022

Last Update

August 31 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of physical therapy - Cairo University

Giza, Egypt, 12613